NYSE:PFEPharmaceuticals
Pfizer’s 2026 Drug Price Reset Could Be A Game Changer For Pfizer (PFE)
Earlier this week, Pfizer confirmed broad list price increases for roughly 80 branded medicines for 2026, including a 15% hike for COVID vaccine Comirnaty, framing the moves as necessary to support investments and higher operating costs amid rising scrutiny of U.S. drug pricing.
This pricing reset comes as Pfizer reshapes its portfolio after the COVID revenue surge, balancing earnings pressure, a heavy dividend commitment, and growing investment in obesity and oncology pipelines.
We'll now...